Cathy Burgess is quoted on the U.S. Food and Drug Administration’s emergency use authorization of remdesivir for treating COVID-19 patients.
In the News
May 1, 2020
Associated Press | FDA Allows for ‘Emergency Use’ of Remdesivir, Experimental Coronavirus Drug
Related News & Insights
-
Medical Products Supply Chain Week in Review January 31, 2022FDA extends pause on non-mission-critical domestic surveillance inspections to February 4 – Medical Products Supply Chain Week in ReviewOSHA withdrew its emergency temporary standard, which required a mandatory vaccination policy for large private employers. The FDA extended its pause on non-mission-critical domestic surveillance inspections to February 4, and the Biden Administration announced that it was making at-home test kits available to the American public. Robert Califf previewed his priorities, if confirmed as commissioner of the FDA, to the Senate HELP Committee. See details for these and other supply chain developments in the Medical Products Supply Chain Week in Review.
-
Press Release January 28, 2022Alston & Bird Adds Former FDA Associate Chief Counsel Alexandra Marzelli as Counsel in Washington, D.C.Alston & Bird has expanded its health care and life sciences regulatory and compliance capabilities with the addition of counsel Alexandra Marzelli, former associate chief counsel at the U.S. Food and Drug Administration (FDA). Based in the firm’s Washington, D.C. office, Marzelli joins Alston & Bird’s Health Care and FDA/Food, Drug & Device Groups, where she will advise clients on the FDA’s complex approval process and regulatory compliance for prescription and over-the-counter drugs, biologics, medical devices, food ingredients, and other products regulated by the agency.
-
In the News March 11, 2021Law360 | The Defining Pandemic Moments for Health and Life Sci AttysCathy Burgess is quoted on the dramatic decline in the Food and Drug Administration’s foreign inspections amid COVID-19.
-
Press Release March 9, 2021Cathy Burgess Honored as a 2021 “Health Care | Life Science Trailblazer” by The National Law JournalCathy Burgess, partner in Alston & Bird’s Health Care Group and leader of the firm’s FDA Compliance & Enforcement Team, has been recognized by The National Law Journal in its third annual list of professionals identified as agents of change in health care and life sciences law.
-
In the News March 1, 2021The Pink Sheet | Drug Manufacturers Beg US FDA to Inspect Facilities, but Still Find DifficultiesCathy Burgess is quoted on COVID-19 safety considerations for Food and Drug Administration inspections.
Media Contact